{"quote": {"result": [{"language": "en-US", "region": "US", "quoteType": "EQUITY", "typeDisp": "Equity", "quoteSourceName": "Delayed Quote", "triggerable": true, "customPriceAlertConfidence": "HIGH", "currency": "USD", "marketState": "PRE", "exchange": "NCM", "regularMarketChangePercent": 3.4482725, "regularMarketPrice": 1.5, "firstTradeDateMilliseconds": 1430746200000, "priceHint": 4, "earningsTimestamp": 1684157100, "earningsTimestampStart": 1691697600, "earningsTimestampEnd": 1692043200, "trailingAnnualDividendRate": 0.0, "trailingAnnualDividendYield": 0.0, "epsTrailingTwelveMonths": -11.29, "epsForward": -10.0, "epsCurrentYear": -12.46, "priceEpsCurrentYear": -0.12038523, "sharesOutstanding": 2078270, "bookValue": 7.06, "fiftyDayAverage": 1.69424, "fiftyDayAverageChange": -0.19423997, "fiftyDayAverageChangePercent": -0.11464726, "twoHundredDayAverage": 3.31604, "twoHundredDayAverageChange": -1.81604, "twoHundredDayAverageChangePercent": -0.54765326, "marketCap": 3590400, "forwardPE": -0.15, "priceToBook": 0.21246459, "sourceInterval": 15, "exchangeDataDelayedBy": 0, "prevName": "Enveric Biosciences Inc.", "nameChangeDate": "2023-05-15", "averageAnalystRating": "2.0 - Buy", "tradeable": false, "cryptoTradeable": false, "shortName": "Enveric Biosciences, Inc.", "longName": "Enveric Biosciences, Inc.", "messageBoardId": "finmb_650902272", "exchangeTimezoneName": "America/New_York", "exchangeTimezoneShortName": "EDT", "gmtOffSetMilliseconds": -14400000, "market": "us_market", "esgPopulated": false, "regularMarketChange": 0.049999952, "regularMarketTime": 1684180792, "regularMarketDayHigh": 1.6133, "regularMarketDayRange": "1.39 - 1.6133", "regularMarketDayLow": 1.39, "regularMarketVolume": 6990, "regularMarketPreviousClose": 1.45, "bid": 0.0, "ask": 0.0, "bidSize": 9, "askSize": 11, "fullExchangeName": "NasdaqCM", "financialCurrency": "USD", "regularMarketOpen": 1.39, "averageDailyVolume3Month": 32963, "averageDailyVolume10Day": 21800, "fiftyTwoWeekLowChange": 0.20000005, "fiftyTwoWeekLowChangePercent": 0.15384619, "fiftyTwoWeekRange": "1.3 - 18.5", "fiftyTwoWeekHighChange": -17.0, "fiftyTwoWeekHighChangePercent": -0.9189189, "fiftyTwoWeekLow": 1.3, "fiftyTwoWeekHigh": 18.5, "dividendDate": 1574640000, "displayName": "Enveric Biosciences", "symbol": "ENVB"}], "error": null}, "summary": {"result": [{"assetProfile": {"address1": "4851 Tamiami Trail N", "address2": "Suite 200", "city": "Naples", "state": "FL", "zip": "34103", "country": "United States", "phone": "(239) 302-1707", "website": "https://www.enveric.com", "industry": "Biotechnology", "industryDisp": "Biotechnology", "sector": "Healthcare", "longBusinessSummary": "Enveric Biosciences, Inc., a biotechnology company, engages in the development of small-molecule therapeutics for the treatment of anxiety, depression, and addiction disorders. Its lead program is EB-373, an active metabolite of psilocybin, which is in Phase 1 clinical trials for the treatment of anxiety disorders; EVM-301 for treating mental health; and EV104 CBD + Celecoxib conjugate for treating osteoarthritis. The company also developing cannabinoid-infused topical product for the treatment of radiodermatitis; and cannabinoid and COX-2 inhibitor conjugation that is in pre-clinical stage for the treatment of OA/acute pain. Enveric Biosciences, Inc. is headquartered in Naples, Florida.", "fullTimeEmployees": 25, "companyOfficers": [{"maxAge": 1, "name": "Dr. Joseph Edward Tucker Ph.D.", "age": 54, "title": "CEO & Director", "yearBorn": 1968, "fiscalYear": 2022, "totalPay": {"raw": 825937, "fmt": "825.94k", "longFmt": "825,937"}, "exercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}, "unexercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}}, {"maxAge": 1, "name": "Mr. Avani V. Kanubaddi", "age": 49, "title": "Pres & COO", "yearBorn": 1973, "fiscalYear": 2022, "totalPay": {"raw": 544971, "fmt": "544.97k", "longFmt": "544,971"}, "exercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}, "unexercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}}, {"maxAge": 1, "name": "Dr. Peter J. Facchini Ph.D.", "age": 58, "title": "Chief Innovation Officer", "yearBorn": 1964, "fiscalYear": 2022, "totalPay": {"raw": 332375, "fmt": "332.38k", "longFmt": "332,375"}, "exercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}, "unexercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}}, {"maxAge": 1, "name": "Mr. Kevin M. Coveney CPA", "age": 58, "title": "Chief Financial Officer", "yearBorn": 1964, "exercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}, "unexercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}}, {"maxAge": 1, "name": "Dr. Ibrahim  Dagher M.D.", "age": 53, "title": "Chief Medical Officer", "yearBorn": 1969, "exercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}, "unexercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}}], "compensationAsOfEpochDate": 1672444800, "maxAge": 86400}}], "error": null}}